NAOGEN PHARMA – Trademark Portfolio

Entity Type: 99

NAOGEN PHARMA holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include KALDENN.

rue du Moulin de la Rousselière

F-44800 Saint-Herblain

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KALDENN
KALDENN
Registered 2024

Trademark Classifications

NAOGEN PHARMA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does NAOGEN PHARMA have?

NAOGEN PHARMA has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does NAOGEN PHARMA file in?

NAOGEN PHARMA files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are NAOGEN PHARMA's most well-known trademarks?

NAOGEN PHARMA's registered trademark portfolio includes well-known marks such as KALDENN. These are among 1 currently registered trademark in the portfolio.

What is NAOGEN PHARMA's trademark registration success rate?

NAOGEN PHARMA has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.